Home › Hypertrophic Cardiomyopathy › New York
Hypertrophic Cardiomyopathy clinical trials in New York
5 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in New York.
Cities in New York
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
- LIONHEART-HCM Site 0107, Manhasset
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Oct 2, 2026 · NCT07755904A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Bassett Medical Center, Cooperstown
- Mount Sinai Hospital, New York
- Saint Francis Hospital, Roslyn
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705Cardiovascular Multimodality Imaging Study
- Montefiore Health System, The Bronx
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06610019Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Columbia University Irving Medical Center, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.